JO
CNTB

John Overdeck’s Connect Biopharma Holdings CNTB Stock Holding History

John Overdeck’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Buy
199,381
+151,916
+320% +$368K ﹤0.01% 4197
2026
Q1 		$124K Buy
+47,465
New +$124K ﹤0.01% 4361
2024
Q2 		– Sell
-10,805
Closed -$18.8K – 3073
2024
Q1 		$18.8K Sell
10,805
-600
-5% -$729 ﹤0.01% 2933
2023
Q4 		$13.5K Sell
11,405
-5,814
-34% -$6.9K ﹤0.01% 3067
2023
Q3 		$14.1K Sell
17,219
-6,367
-27% -$5.8K ﹤0.01% 2887
2023
Q2 		$26.7K Buy
+23,586
New +$26.4K ﹤0.01% 2887
2022
Q3 		– Sell
-28,016
Closed -$24K – 2518
2022
Q2 		$24K Buy
+28,016
New +$41.3K ﹤0.01% 2393
2022
Q1 		– Sell
-15,632
Closed -$81K – 2953
2021
Q4 		$81K Buy
+15,632
New +$174K ﹤0.01% 4094

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

John Overdeck's CNTB Position: Q2 2026 in Review

John Overdeck increased its Connect Biopharma Holdings (CNTB) stake by 320% in Q2 2026, buying an estimated $368K and bringing the position to 199,381 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #4197.

John Overdeck first reported a position in CNTB in Q4 2021 and has held it in 8 quarters since. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • John Overdeck held 199,381 shares of Connect Biopharma Holdings worth $475K as of Q2 2026.
  • John Overdeck bought 151,916 Connect Biopharma Holdings shares in Q2 2026, an estimated $368K.
  • Connect Biopharma Holdings made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4197 holding.
  • John Overdeck first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 8 quarters since.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.